- call +1-201-465-4211
- email sales@mrinsights.biz
Market Overview
The global Orthobiologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Orthobiologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Orthobiologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Orthobiologics market has been segmented into:
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
By Application, Orthobiologics has been segmented into:
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Orthobiologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Orthobiologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Orthobiologics market.
The report offers in-depth assessment of the growth and other aspects of the Orthobiologics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Orthobiologics Market Share Analysis
Orthobiologics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Orthobiologics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Orthobiologics sales, revenue and market share for each player covered in this report.
The major players covered in Orthobiologics are:
Medtronic
Bioventus
Zimmer Biomet Holdings
NuVasive, Inc.
DePuy Synthes (Johnson & Johnson)
Stryker Corporation
SeaSpine Holdings Corporation
Anika Therapeutics, Inc.
Orthofix International N.V.
Arthrex, Inc.
Heraeus Holding GmbH
Allosource
Sanofi-Aventis (Sanofi SA)
Ito
Fidia Pharma USA Inc.
RTI Surgical, Inc.
Djo Global, Inc.
Musculoskeletal Transplant Foundation, Inc.
TRB Chemedica International SA
Seikagaku Corporation
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Orthobiologics Market Overview
1.1 Product Overview and Scope of Orthobiologics
1.2 Classification of Orthobiologics by Type
1.2.1 Global Orthobiologics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Orthobiologics Revenue Market Share by Type in 2019
1.2.3 Bone Growth Stimulators (BGS)
1.2.4 Viscosupplements
1.2.5 Bone Graft Substitute
1.3 Global Orthobiologics Market by Application
1.3.1 Overview: Global Orthobiologics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centres
1.3.4 Orthopaedics Clinics
1.4 Global Orthobiologics Market by Regions
1.4.1 Global Orthobiologics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Orthobiologics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Orthobiologics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Orthobiologics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Orthobiologics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Orthobiologics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Orthobiologics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bioventus
2.2.1 Bioventus Details
2.2.2 Bioventus Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bioventus SWOT Analysis
2.2.4 Bioventus Product and Services
2.2.5 Bioventus Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zimmer Biomet Holdings
2.3.1 Zimmer Biomet Holdings Details
2.3.2 Zimmer Biomet Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Zimmer Biomet Holdings SWOT Analysis
2.3.4 Zimmer Biomet Holdings Product and Services
2.3.5 Zimmer Biomet Holdings Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.4 NuVasive, Inc.
2.4.1 NuVasive, Inc. Details
2.4.2 NuVasive, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 NuVasive, Inc. SWOT Analysis
2.4.4 NuVasive, Inc. Product and Services
2.4.5 NuVasive, Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.5 DePuy Synthes (Johnson & Johnson)
2.5.1 DePuy Synthes (Johnson & Johnson) Details
2.5.2 DePuy Synthes (Johnson & Johnson) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DePuy Synthes (Johnson & Johnson) SWOT Analysis
2.5.4 DePuy Synthes (Johnson & Johnson) Product and Services
2.5.5 DePuy Synthes (Johnson & Johnson) Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Stryker Corporation
2.6.1 Stryker Corporation Details
2.6.2 Stryker Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Stryker Corporation SWOT Analysis
2.6.4 Stryker Corporation Product and Services
2.6.5 Stryker Corporation Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.7 SeaSpine Holdings Corporation
2.7.1 SeaSpine Holdings Corporation Details
2.7.2 SeaSpine Holdings Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SeaSpine Holdings Corporation SWOT Analysis
2.7.4 SeaSpine Holdings Corporation Product and Services
2.7.5 SeaSpine Holdings Corporation Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Anika Therapeutics, Inc.
2.8.1 Anika Therapeutics, Inc. Details
2.8.2 Anika Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Anika Therapeutics, Inc. SWOT Analysis
2.8.4 Anika Therapeutics, Inc. Product and Services
2.8.5 Anika Therapeutics, Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Orthofix International N.V.
2.9.1 Orthofix International N.V. Details
2.9.2 Orthofix International N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Orthofix International N.V. SWOT Analysis
2.9.4 Orthofix International N.V. Product and Services
2.9.5 Orthofix International N.V. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Arthrex, Inc.
2.10.1 Arthrex, Inc. Details
2.10.2 Arthrex, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Arthrex, Inc. SWOT Analysis
2.10.4 Arthrex, Inc. Product and Services
2.10.5 Arthrex, Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Heraeus Holding GmbH
2.11.1 Heraeus Holding GmbH Details
2.11.2 Heraeus Holding GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Heraeus Holding GmbH SWOT Analysis
2.11.4 Heraeus Holding GmbH Product and Services
2.11.5 Heraeus Holding GmbH Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Allosource
2.12.1 Allosource Details
2.12.2 Allosource Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Allosource SWOT Analysis
2.12.4 Allosource Product and Services
2.12.5 Allosource Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sanofi-Aventis (Sanofi SA)
2.13.1 Sanofi-Aventis (Sanofi SA) Details
2.13.2 Sanofi-Aventis (Sanofi SA) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sanofi-Aventis (Sanofi SA) SWOT Analysis
2.13.4 Sanofi-Aventis (Sanofi SA) Product and Services
2.13.5 Sanofi-Aventis (Sanofi SA) Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ito
2.14.1 Ito Details
2.14.2 Ito Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ito SWOT Analysis
2.14.4 Ito Product and Services
2.14.5 Ito Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Fidia Pharma USA Inc.
2.15.1 Fidia Pharma USA Inc. Details
2.15.2 Fidia Pharma USA Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Fidia Pharma USA Inc. SWOT Analysis
2.15.4 Fidia Pharma USA Inc. Product and Services
2.15.5 Fidia Pharma USA Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.16 RTI Surgical, Inc.
2.16.1 RTI Surgical, Inc. Details
2.16.2 RTI Surgical, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 RTI Surgical, Inc. SWOT Analysis
2.16.4 RTI Surgical, Inc. Product and Services
2.16.5 RTI Surgical, Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Djo Global, Inc.
2.17.1 Djo Global, Inc. Details
2.17.2 Djo Global, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Djo Global, Inc. SWOT Analysis
2.17.4 Djo Global, Inc. Product and Services
2.17.5 Djo Global, Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Musculoskeletal Transplant Foundation, Inc.
2.18.1 Musculoskeletal Transplant Foundation, Inc. Details
2.18.2 Musculoskeletal Transplant Foundation, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Musculoskeletal Transplant Foundation, Inc. SWOT Analysis
2.18.4 Musculoskeletal Transplant Foundation, Inc. Product and Services
2.18.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.19 TRB Chemedica International SA
2.19.1 TRB Chemedica International SA Details
2.19.2 TRB Chemedica International SA Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 TRB Chemedica International SA SWOT Analysis
2.19.4 TRB Chemedica International SA Product and Services
2.19.5 TRB Chemedica International SA Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Seikagaku Corporation
2.20.1 Seikagaku Corporation Details
2.20.2 Seikagaku Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Seikagaku Corporation SWOT Analysis
2.20.4 Seikagaku Corporation Product and Services
2.20.5 Seikagaku Corporation Orthobiologics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Orthobiologics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Orthobiologics Players Market Share
3.2.2 Top 10 Orthobiologics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Orthobiologics Revenue and Market Share by Regions
4.2 North America Orthobiologics Revenue and Growth Rate (2015-2020)
4.3 Europe Orthobiologics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Orthobiologics Revenue and Growth Rate (2015-2020)
4.5 South America Orthobiologics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Orthobiologics Revenue and Growth Rate (2015-2020)
5 North America Orthobiologics Revenue by Countries
5.1 North America Orthobiologics Revenue by Countries (2015-2020)
5.2 USA Orthobiologics Revenue and Growth Rate (2015-2020)
5.3 Canada Orthobiologics Revenue and Growth Rate (2015-2020)
5.4 Mexico Orthobiologics Revenue and Growth Rate (2015-2020)
6 Europe Orthobiologics Revenue by Countries
6.1 Europe Orthobiologics Revenue by Countries (2015-2020)
6.2 Germany Orthobiologics Revenue and Growth Rate (2015-2020)
6.3 UK Orthobiologics Revenue and Growth Rate (2015-2020)
6.4 France Orthobiologics Revenue and Growth Rate (2015-2020)
6.5 Russia Orthobiologics Revenue and Growth Rate (2015-2020)
6.6 Italy Orthobiologics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Orthobiologics Revenue by Countries
7.1 Asia-Pacific Orthobiologics Revenue by Countries (2015-2020)
7.2 China Orthobiologics Revenue and Growth Rate (2015-2020)
7.3 Japan Orthobiologics Revenue and Growth Rate (2015-2020)
7.4 Korea Orthobiologics Revenue and Growth Rate (2015-2020)
7.5 India Orthobiologics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Orthobiologics Revenue and Growth Rate (2015-2020)
8 South America Orthobiologics Revenue by Countries
8.1 South America Orthobiologics Revenue by Countries (2015-2020)
8.2 Brazil Orthobiologics Revenue and Growth Rate (2015-2020)
8.3 Argentina Orthobiologics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Orthobiologics by Countries
9.1 Middle East & Africa Orthobiologics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Orthobiologics Revenue and Growth Rate (2015-2020)
9.3 UAE Orthobiologics Revenue and Growth Rate (2015-2020)
9.4 Egypt Orthobiologics Revenue and Growth Rate (2015-2020)
9.5 South Africa Orthobiologics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Orthobiologics Revenue and Market Share by Type (2015-2020)
10.2 Global Orthobiologics Market Forecast by Type (2019-2024)
10.3 Bone Growth Stimulators (BGS) Revenue Growth Rate (2015-2025)
10.4 Viscosupplements Revenue Growth Rate (2015-2025)
10.5 Bone Graft Substitute Revenue Growth Rate (2015-2025)
11 Global Orthobiologics Market Segment by Application
11.1 Global Orthobiologics Revenue Market Share by Application (2015-2020)
11.2 Orthobiologics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centres Revenue Growth (2015-2020)
11.5 Orthopaedics Clinics Revenue Growth (2015-2020)
12 Global Orthobiologics Market Size Forecast (2021-2025)
12.1 Global Orthobiologics Market Size Forecast (2021-2025)
12.2 Global Orthobiologics Market Forecast by Regions (2021-2025)
12.3 North America Orthobiologics Revenue Market Forecast (2021-2025)
12.4 Europe Orthobiologics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Orthobiologics Revenue Market Forecast (2021-2025)
12.6 South America Orthobiologics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Orthobiologics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Orthobiologics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Orthobiologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3.
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
